CARD9 S12N RISK ALLELE

Clinical trials for CARD9 S12N RISK ALLELE explained in plain language.

Never miss a new study

Get alerted when new CARD9 S12N RISK ALLELE trials appear

Sign up with your email to follow new studies for CARD9 S12N RISK ALLELE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Targeted fungus fight: a genetic approach to taming Crohn's

Disease control Terminated

This study tested whether treating a specific gut fungus with the antifungal drug posaconazole could reduce inflammation in people with active Crohn's disease who have a particular genetic risk (CARD9 S12N). It was a small, placebo-controlled trial that looked for improvements in…

Matched conditions: CARD9 S12N RISK ALLELE

Phase: PHASE4 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

CARD9 S12N RISK ALLELE

Get alerted when new CARD9 S12N RISK ALLELE trials appear

Targeted fungus fight: a genetic approach to taming Crohn's